IN RE GALECTIN THERAPEUTICS SECURITIES LITIGATION

No. 16-10324.

843 F.3d 1257 (2016)

IN RE: GALECTIN THERAPEUTICS, INC. SECURITIES LITIGATION, Marissa Ballesteros, et al., Plaintiffs, Glyn Hotz, Lead Plaintiff, Plaintiff-Appellant, v. Galectin Therapeutics, Inc., James C. Czirr, Peter G. Traber, Jack W. Callicutt, 3:14-cv-402-RCJ-WGC, Rod D. Martin, John F. Mauldin, 10x Fund L.P. Member Case 3:14-cv-402-RCJ-WGC, et al., Defendants-Appellees, Gilbert F. Amelio, Member Case 3:14-cv-402-RCJ-WGC, et al., Defendants.

United States Court of Appeals, Eleventh Circuit.

Date Filed: December 15, 2016.


Attorney(s) appearing for the Case

Kimberly A. Justice , Michael K. Yarnoff , Naumon A. Amjed , Ryan T. Degnan , Meredith L. Lambert , Kessler Topaz Meltzer & Check, LLP, Radnor, PA, Ross A. Albert , Morris Manning & Martin, LLP, Atlanta, GA, for Plaintiff-Appellant.

Michael R. Smith , Benjamin Lee , Alexandra Spear Peurach , Benjamin Warren Pope , King & Spalding, LLP, Atlanta, GA, for Defendants-Appellees.

Before TJOFLAT and HULL, Circuit Judges, and BYRON, District Judge.


Appellee-defendant Galectin Therapeutics, Inc. ("Galectin") is a small biopharmaceutical company headquartered in Norcross, Georgia. On February 26, 2014, Appellant-plaintiff Glynn Hotz purchased 16,000 shares of Galectin common stock at $17.90 per share. On July 25, 2014, news outlets began to report that Galectin had paid...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases